Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal Biology

Biology

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Published: February 17, 2023 doi: 10.3791/64977
Automatic Translation
1,2, 3, 1,2, 4, 1,2, 1,2
1Key Laboratory of Brain, Cognition and Education Science, Ministry of Education, 2Institute for Brain Research and Rehabilitation, Guangdong Key Laboratory of Mental Health and Cognitive Science, South China Normal University, 3Institute of Modern Aquaculture Science and Engineering, Guangdong Provincial Engineering Technology Research Center for Environmentally Friendly Aquaculture, Guangdong Provincial Key Laboratory for Healthy and Safe Aquaculture, School of Life Sciences, South China Normal University, 4Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences

Summary

This protocol describes how to perform efficient adenine base editing without PAM limitation to construct a precise zebrafish disease model using zSpRY-ABE8e.

Abstract

CRISPR/Cas9 technology has increased the value of zebrafish for modeling human genetic diseases, studying disease pathogenesis, and drug screening, but protospacer adjacent motif (PAM) limitations are a major obstacle to creating accurate animal models of human genetic disorders caused by single-nucleotide variants (SNVs). Until now, some SpCas9 variants with broad PAM compatibility have shown efficiency in zebrafish. The application of the optimized SpRY-mediated adenine base editor (ABE), zSpRY-ABE8e, and synthetically modified gRNA in zebrafish has enabled efficient adenine-guanine base conversion without PAM restriction. Described here is a protocol for efficient adenine base editing without PAM limitation in zebrafish using zSpRY-ABE8e. By injecting a mixture of zSpRY-ABE8e mRNA and synthetically modified gRNA into zebrafish embryos, a zebrafish disease model was constructed with a precise mutation that simulated a pathogenic site of the TSR2 ribosome maturation factor (tsr2). This method provides a valuable tool for the establishment of accurate disease models for studying disease mechanisms and treatments.

Introduction

Single-nucleotide variants (SNVs) that cause missense or nonsense mutations are the most common source of mutations in the human genome1. To determine whether a particular SNV is pathogenic, and to shed light on its pathogenesis, precise animal models are required2. Zebrafish are good human disease models, exhibiting a high degree of physiological and genetic homology with humans, a short developmental cycle, and strong reproductive ability, which is advantageous for research into pathogenic characteristics and mechanisms, as well as drug screening3.

The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system has been widely applied in the genome editing of various species, including zebrafish4. With gRNA guidance, the CRISPR/Cas9 system can generate DNA double-stranded breaks (DSBs) at the target site, which then allows single-base substitution through recombination of the target site with donor DNA templates via the homology-directed repair (HDR) pathway. However, the efficiency of this base replacement method is quite low as the cellular DNA repair process is mainly carried out by the non-homologous end-joining (NHEJ) pathway, which is usually accompanied by insertion and deletion (indel) mutations5. Fortunately, CRISPR/Cas9-based single-base editing technology significantly alleviates this problem by using base editors, which enable more efficient single-base editing without inducing DSBs. Two major classes of base editors, adenine base editors (ABEs) and cytosine base editors (CBEs), have been developed to implement base substitution editing for A·T to G·C and C·G to T·A, respectively6,7,8,9,10,11. These four types of base substitutions cover 30% of human pathogenic variants12. Both classes of base editors, including PmCDA1, BE system, CBE4max, ABE7.10, and ABE8e, have been reported to work in zebrafish, with BE4max and ABE8e especially reported to achieve high editing activity13,14,15,16,17,18,19.

Cas9 proteins from different species, including Staphylococcus aureus, Streptococcus pyogenes, and S. canis, have been implemented in zebrafish gene editing, with the Streptococcus pyogenes Cas9 (SpCas9) being used most widely20,21,22,23. However, SpCas9 can only recognize target sites with an NGG protospacer adjacent motif (PAM), which limits its editable range and can result in no suitable sequence being found near the pathogenic site of interest24. To expand the target range, a variety of SpCas9 variants have been engineered to recognize different PAMs through directed evolution and structure-guided design. However, few variants are effective in animals, especially in zebrafish, which limits the application of zebrafish in SNV-related disease research25,26,27,28. Recently, two variants of SpCas9, SpG and SpRY, with less stringent PAM restrictions (NGN for SpG and NNN for SpRY with a higher preference for NRN than NYN) have been reported to exhibit high editing activity in human cells and plants29,30,31,32. Subsequently, SpG and SpRY, as well as a number of their mediated base editors, such as SpRY-mediated CBEs and SpRY-mediated ABEs, have also been reported to work in zebrafish, which will enhance the application of zebrafish models in the mechanistic study and drug screening of SNV-related diseases18,33,34,35. Furthermore, i-Silence was proposed as an effective and accurate gene-knockout strategy through ABE-mediated start codon conversion from ATG to GTG or ACG36. The combination of the i-Silence strategy and the SpRY-mediated base editor zSpRY-ABE8e provides a new method for disease modeling18. This protocol demonstrates how to perform gene editing using zSpRY-ABE8e in zebrafish to construct a tsr2 (M1V) model using the i-Silence strategy. The editing efficiency and phenotypes that appear in zebrafish models were assessed and analyzed.

Subscription Required. Please recommend JoVE to your librarian.

Protocol

This study was conducted in strict compliance with the guidelines of the Care and Use Committee of the South China Normal University.

1. Preparing synthetically modified gRNA and zSpRY-ABE8e mRNA

  1. Design the gRNA according to previous publications37,38.
    1. Preferentially select NRN as the PAM sequence, as zSpRY-ABE8e shows a higher preference for NRN PAM than NYN PAM (where R is A or G, and Y is C or T)18. Ensure that the target adenine nucleotide is in the highly active editing window (third to ninth nucleotide along the protospacer).
  2. Order EasyEdit sgRNA (EE gRNA) modified with 2′-O-methyl-3′-phosphorothioate (MS) at both ends (Figure 1).
    NOTE: The EE gRNA should be dissolved in RNase-free water and stored at −80 °C.
  3. Linearize the zSpRY-ABE8e plasmid18.
    1. Linearize 6 µg of the plasmid with the XbaI enzyme (Table of Materials) in a metal bath at 37 °C for 3 h.
    2. Purify the linearized plasmid using the DNA purification kit (see Table of Materials) according to the manufacturer's instructions.
  4. Transcribe the mRNA using the in vitro transcription kit (Table of Materials).
    1. Transcribe the zSpRY-ABE8e mRNA with the linearized plasmid as template according to the manufacturer's instructions.
      NOTE: All operations involving mRNA and gRNA require the use of RNase-free laboratory supplies.
  5. Use the RNA purification kit (Table of Materials) to purify the mRNA according to the manufacturer's instructions.
    NOTE: Before eluting, the ethanol must be dried to avoid cytotoxicity, and the mRNA should be stored at −80 °C if not used immediately.

2. Preparing microinjection glass capillaries

  1. Set up the micropipette puller system, and preheat for at least 30 min.
  2. Run a ramp test to determine the heat value needed to melt the borosilicate glass capillaries (with 1 mm outer diameter and 0.58 mm inner diameter) according to the manufacturer's instructions.
  3. Select a program, and click on the number on the keyboard to enter the parameter values. Set the following parameters to pull the glass capillaries: heat = ramp test value, pull = 50, velocity = 100, time = 50, and pressure = 30.
  4. Install the capillary tube, ensuring it is in the groove. Press PULL START/STOP to run the program.
  5. Preserve the pulled capillaries by inserting them into foam that contains gaps, keeping the needle suspended.

3. Microinjection of the zSpRY-ABE8e mRNA and EE gRNA mixture into zebrafish embryos

  1. Set up breeding tanks the night before the injection. Insert a divider, place two females and one male AB strain zebrafish (3-18 months old) in each tank, and cover with the lid. Refer to previous publications for gender distinctions39.
    NOTE: To obtain more embryos, select fish that have not been breeding for at least 1 week.
  2. The next morning before the injection, thaw the zSpRY-ABE8e mRNA and EE gRNA on ice. Mix the mRNA and gRNA to final concentrations of 400 ng/µL and 200 ng/µL, respectively.
    1. Perform the entire procedure on ice using RNase-free tips and tubes, and handle with gloves.
  3. Configure the pneumatic microinjector. Close the partial pressure valve of the air pump and open the main valve first, unscrew the gas cylinder, and adjust the pressure of the partial pressure valve to 0.2 MPa/29 psi.
    1. Turn on the pneumatic microinjector, set the mode to TIMER, and adjust the initial parameter pressure value to 20.0 psi and the TIMER value to 0.040 s.
  4. Use fine forceps to carefully break the needles of the pulled glass capillaries under a stereomicroscope, making sure the needles are cut at an angle to facilitate the piercing of the chorion and the egg.
    NOTE: The break point of the needle needs to be in the right place and be strong enough to pierce the egg yet thin enough to minimize damage to the egg.
  5. Add the mixture of zSpRY-ABE8e mRNA and gRNA to the tip of a glass capillary using a microloader pipette tip, avoiding bubbles in the capillary. Attach the needle to the micromanipulator, and configure the pressure and TIMER value of the injector to ensure 2 nL of mixture is produced per injection using a microcap.
  6. Unplug the dividers of the breeding tanks, and allow the fish to breed for 10-15 min. Collect the eggs using a strainer, and examine the cell stage and quality of the eggs under a stereomicroscope. Select the eggs in the single-cell state for injection to improve the editing efficiency.
  7. Line the eggs on a 1.5% agarose injection plate, and inject 2 nL of the mixture into the cell, not the yolk, of the embryos under a microscope to improve the editing efficiency. Retain at least 15 eggs as the control group.
  8. Use 1x E3 buffer to collect the eggs in Petri dishes, and place them in an incubator at 28 °C. Remove the dead eggs, and change the culture buffer every 12 h until 48 hours post fertilization (hpf).

4. Efficiency analysis of base editing with EditR

  1. At 48 hpf, collect three pools of six randomly selected injected embryos and six randomly selected control embryos into PCR tubes respectively. Use a pipette to aspirate the residual E3 buffer.
  2. Add 40 µL of 50 mM NaOH into the PCR tubes. Put the tubes in a metal bath at 95 °C for 20 min, and then vortex for 15 s.
  3. Add 4 µL of 1 M Tris·HCl (pH 8.0) into each tube to neutralize the NaOH. Briefly centrifuge at 2,000 x g for 10 s at room temperature to remove droplets from the tube wall. Collect the supernatant into new PCR tubes, and store them at −20 °C.
  4. Design appropriate primers upstream and downstream of the gRNA target sites. Use 1 µL of the above supernatant as template for the PCR reactions of 50 µL volume. The primers used for the PCR in this study are listed in Supplementary Table 1.
  5. Perform a DNA agarose gel electrophoresis to ensure correct and specific bands, followed by Sanger sequencing as previously described40.
  6. Analyze the Sanger sequencing data with the EditR (1.0.10) program41.
    1. Upload the sequencing file (ab1 format) into the "Upload .ab1 File" box.
    2. Enter the 20 bp gRNA sequence in 5′-3′ orientation into the "Enter gRNA sequence" box.
    3. Open the sequencing file (ab1 format), and confirm the base positions where the 20 bp gRNA sequence starts and ends. Enter the corresponding base position in the "5′ start" and "3′ end" boxes.
    4. Click on Predicted Editing to obtain the base editing efficiency. Check the quality of the sequencing data near the gRNA target sequence to avoid disorderly peaks or indels.
      NOTE: In general, the disorderly peaks can be effectively removed by adjusting the PCR annealing temperature.

Subscription Required. Please recommend JoVE to your librarian.

Representative Results

The mutation of TSR2 has been reported to cause Diamond Blackfan anemia (DBA)42. Here, a DBA zebrafish model was constructed with a tsr2 (M1V) mutation using the i-Silence strategy. The adenine of the start codon of the zebrafish tsr2 was successfully converted to guanine using zSpRY-ABE8e (Figure 3).

The EditR analysis of the Sanger sequencing results showed that there was an A/G overlap at the adenine base of the tsr2 start codon (Figure 4).

After F0 founders were mated with a previously generated tsr2 heterozygous mutant adult, the embryo phenotypes were observed at 2 days post fertilization (dpf) under the microscope. Several embryos exhibited a phenotype of smaller eyes and a swollen pericardium compared with controls (Figure 5). The embryos were anesthetized with 0.03% Tricaine, fixed on 4% methylcellulose, and photographed.

Figure 1
Figure 1: Schematic diagram of the sequence and secondary structure of EE gRNA loaded into zSpRY-ABE8e protein. The chemically modified nucleotides are labeled with black stars. Please click here to view a larger version of this figure.

Figure 2
Figure 2: Schematic diagram of the zSpRY-ABE8e mRNA structure containing codon-optimized TadA8e (zTadA8e) and codon-optimized SpRYCas9 (zSpRYCas9). Please click here to view a larger version of this figure.

Figure 3
Figure 3: Schematic diagram of the zebrafish tsr2 (M1V) mutation using zSpRY-ABE8e. The PAM sequences are highlighted in red, the edited bases are highlighted in blue, and the targeted amino acids are in bold. Please click here to view a larger version of this figure.

Figure 4
Figure 4: Sequencing chromatogram results of the zebrafish tsr2 (M1V) mutation using zSpRY-ABE8e. The x-axis represents the base sequence, the y-axis represents the peak height, and the edited base is indicated with a red arrowhead. Please click here to view a larger version of this figure.

Figure 5
Figure 5: Phenotype of the tsr2 (M1V) embryos at 2 dpf compared with controls. (A,C) The lateral view and (B,D) dorsal view of (A,B) wild-type AB zebrafish and (C,D) tsr2 (M1V) embryos at 2 dpf. The red arrowhead in C indicates pericardial swelling. The red frame and diameter reflect the eye size. Scale bar: 500 µm. Please click here to view a larger version of this figure.

Supplemental Table 1: Please click here to download this File.

Subscription Required. Please recommend JoVE to your librarian.

Discussion

This protocol describes the construction of a zebrafish disease model using the base editor zSpRY-ABE8e. Compared with the traditional HDR pathway for base substitution, this protocol can achieve more efficient base editing and reduce the occurrence of indels. At the same time, this protocol involves implementing the recently proposed i-Silence gene-knockout strategy in zebrafish. Taken together, zSpRY-ABE8e will enhance the application of zebrafish models in disease research.

Off-target effects are a common problem in CRISPR/Cas9 systems. Considering the PAM-less restriction, the off-target effect of zSpRY-ABE8e may be higher, even if no significant off-target was found in a previous study including tsr2 targeting18. Fortunately, this problem can be avoided by strict gRNA design standards, which ensure that only one genome sequence matches the gRNA with PAM exactly and keep the total number of predicted off-target sites to a minimum. Additionally, a study has shown that the injection of ribonucleoprotein (RNP) and gRNA reduces the off-target probability compared with the injection of mRNA and gRNA43. Furthermore, the modification of gRNA and Cas9 can also reduce off-target effects44,45. In zebrafish, multiple generations of breeding can also be screened for the target phenotypes to obtain animal models with low off-target effects.

There are still some limitations in this protocol. Although zSpRY-ABE8e has no PAM restriction, it still exhibits PAM preference, with NRN preferred to NYN in zebrafish. Furthermore, the ABE can only implement two types of base substitution, meaning it is only applicable to the construction of partial models. More base editors still need to be developed to implement the remaining base substitutions in zebrafish.

In conclusion, this protocol provides detailed guidance for the use of the zSpRY-ABE8e single base editor in zebrafish. It provides a feasible and efficient method to construct precise zebrafish disease models, expanding the application of zebrafish models in studies of the pathogenesis and treatment of SNV-related diseases.

Subscription Required. Please recommend JoVE to your librarian.

Disclosures

The authors declare no conflicts of interest.

Acknowledgments

We thank Barbara Garbers, PhD, from Liwen Bianji (Edanz) for editing the English text of a draft of this manuscript. This work was supported by the Key-Area Research and Development Program of Guangdong Province (2019B030335001), the National Key R&D Program of China (2019YFE0106700), the National Natural Science Foundation of China (32070819, 31970782), and the Research Fund Program of Guangdong Provincial Key Lab of Pathogenic Biology and Epidemiology for Aquatic Economic Animals (PBEA2020YB05).

Materials

Name Company Catalog Number Comments
Agarose Sigma-Aldrich A9539 1.5% Agarose used to make an injection plate
Borosilicate Glass Capillaries  Harvard Apparatus BS4 30-0016
Cell culture dishes  Falcon 351029
ClonExpress Ultra One Step Cloning Kit Vazyme C115 Kit for Infusion clone 
Codon optimization service Sangon Biotech
Drummond Microcaps Drummond Microcaps P1299-1PAK Length:32 mm, capacity:0.5 μL
EasyEdit gRNA service GenScript
Fine Forceps Fine Scientific Instrument 11254-20 Used to break meedle
Flaming/Brown Micropipette Puller  Stutter Instrument P-97 Used to pull the glass capillaries
HotStart Taq PCR StarMix Genstar A033-101 Used for PCR reaction
Intelligent artificial climate box TENLIN PRX-1000A Used to culture zebrafish embryos
Methylcellulose Sigma-Aldrich M0512 Used to fix zebrafish when photographing
Microloader pipette tips  Eppendorf 5242956003
mMACHINE kit 
Mut Express II Fast Mutagenesis Kit V2 Vazyme C214-01 Kit for site-directed mutagenesis
Pneumatic Microinjector ZGene Biotech ZGPCP-1500 PLUS
pT3TS-zSpCas9 Addgene 46757
RNeasy FFPE kit  Qiagen 73504 Kit for RNA purification
Sanger Sequencing service Sangon Biotech
Sodium hydroxide, granular Sangon A100173-0500 NaOH used for genome extraction
Stereo Microscope Olympus  SZX10 Used for photograph of phenotype
SZ Series Zoom Stereo Microscope CNOPTEC SZ650
T3 mMESSAGE Ambion AM1348 Kit for in vitro transcription 
TIANprep Mini Plasmid Kit TIANGEN DP103-03 Kit for plasmid extraction kit
TIANquick Mini Purification Kit TIANGEN DP203-02 Kit for purification for linearized plasmid
Tricaine Sigma-Aldrich E10521 Used to anesthetize zebrafish
Tris (hydroxymethyl) aminomethane Sangon A600194-0500 Component of Tris·HCl used for genome extraction
XbaI New England Biolabs R0145S Restriction endonuclease used for plasmid linearization

DOWNLOAD MATERIALS LIST

References

  1. Eichler, E. E., et al. Completing the map of human genetic variation. Nature. 447 (7141), 161-165 (2007).
  2. Koukouli, F., et al. Nicotine reverses hypofrontality in animal models of addiction and schizophrenia. Nature Medicine. 23 (3), 347-354 (2017).
  3. Kalueff, A. V., Stewart, A. M., Gerlai, R. Zebrafish as an emerging model for studying complex brain disorders. Trends in Pharmacological Sciences. 35 (2), 63-75 (2014).
  4. Anzalone, A. V., Koblan, L. W., Liu, D. R. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nature Biotechnology. 38 (7), 824-844 (2020).
  5. Sander, J. D., Joung, J. K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nature Biotechnology. 32 (4), 347-355 (2014).
  6. Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 533 (7603), 420-424 (2016).
  7. Nishida, K., et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science. 353 (6305), (2016).
  8. Gaudelli, N. M., et al. Directed evolution of adenine base editors with increased activity and therapeutic application. Nature Biotechnology. 38 (7), 892-900 (2020).
  9. Liu, Z., et al. Highly efficient RNA-guided base editing in rabbit. Nature Communications. 9, 2717 (2018).
  10. Levy, J. M., et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nature Biomedical Engineering. 4 (1), 97-110 (2020).
  11. Liu, Z., et al. Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing. Nature Communications. 9, 2338 (2018).
  12. Landrum, M. J., et al. ClinVar: Public archive of interpretations of clinically relevant variants. Nucleic Acids Research. 44, 862-868 (2016).
  13. Qin, W., et al. Precise A•T to G•C base editing in the zebrafish genome. BMC Biology. 16 (1), 139 (2018).
  14. Tanaka, S., et al. In vivo targeted single-nucleotide editing in zebrafish. Scientific Reports. 8, 11423 (2018).
  15. Carrington, B., Weinstein, R. N., Sood, R. BE4max and AncBE4max are efficient in germline conversion of C:G to T:A base pairs in zebrafish. Cells. 9 (7), 1690 (2020).
  16. Zhang, Y., et al. Programmable base editing of zebrafish genome using a modified CRISPR-Cas9 system. Nature Communications. 8, 118 (2017).
  17. Rosello, M., et al. Precise base editing for the in vivo study of developmental signaling and human pathologies in zebrafish. eLife. 10, 65552 (2021).
  18. Liang, F., et al. SpG and SpRY variants expand the CRISPR toolbox for genome editing in zebrafish. Nature Communications. 13, 3421 (2022).
  19. Qin, W., Lu, X., Lin, S. Programmable base editing in zebrafish using a modified CRISPR-Cas9 system. Methods. 150, 19-23 (2018).
  20. Feng, Y., et al. Expanding CRISPR/Cas9 genome editing capacity in zebrafish using SaCas9. G3. 6 (8), 2517-2521 (2016).
  21. Liu, Y., et al. Genome editing in zebrafish by ScCas9 recognizing NNG PAM. Cells. 10 (8), 2099 (2021).
  22. Kleinstiver, B. P., et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature. 523 (7561), 481-485 (2015).
  23. Liu, K., Petree, C., Requena, T., Varshney, P., Varshney, G. K. Expanding the CRISPR toolbox in zebrafish for studying development and disease. Frontiers in Cell and Developmental Biology. 7, 13 (2019).
  24. Jinek, M., et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 337 (6096), 816-821 (2012).
  25. Hu, J. H., et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature. 556 (7699), 57-63 (2018).
  26. Nishimasu, H., et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science. 361 (6408), 1259-1262 (2018).
  27. Endo, M., et al. Genome editing in plants by engineered CRISPR-Cas9 recognizing NG PAM. Nature Plants. 5, 14-17 (2019).
  28. Li, J., et al. Plant genome editing using xCas9 with expanded PAM compatibility. Journal of Genetics and Genomics. 46 (5), 277-280 (2019).
  29. Ren, Q., et al. PAM-less plant genome editing using a CRISPR-SpRY toolbox. Nature Plants. 7, 25-33 (2021).
  30. Xu, Z., et al. SpRY greatly expands the genome editing scope in rice with highly flexible PAM recognition. Genome Biology. 22 (1), 6 (2021).
  31. Walton, R. T., Christie, K. A., Whittaker, M. N., Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science. 368 (6488), 290-296 (2020).
  32. Li, J., et al. Genome editing mediated by SpCas9 variants with broad non-canonical PAM compatibility in plants. Molecular Plant. 14 (2), 352-360 (2021).
  33. Vicencio, J., et al. Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes. Nature Communications. 13, 2601 (2022).
  34. Rosello, M., et al. Disease modeling by efficient genome editing using a near PAM-less base editor in vivo. Nature Communications. 13, 3435 (2022).
  35. Cornean, A., et al. Precise in vivo functional analysis of DNA variants with base editing using ACEofBASEs target prediction. eLife. 11, 72124 (2022).
  36. Wang, X., et al. Efficient gene silencing by adenine base editor-mediated start codon mutation. Molecular Therapy. 28 (2), 431-440 (2020).
  37. Hanna, R. E., Doench, J. G. Design and analysis of CRISPR-Cas experiments. Nature Biotechnology. 38 (7), 813-823 (2020).
  38. Doench, J. G., et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nature Biotechnology. 34 (2), 184-191 (2016).
  39. Kossack, M. E., Draper, B. W. Genetic regulation of sex determination and maintenance in zebrafish (Danio rerio). Current Topics in Developmental Biology. 134, 119-149 (2019).
  40. Crossley, B. M., et al. Guidelines for Sanger sequencing and molecular assay monitoring. Journal of Veterinary Diagnostic Investigation. 32 (6), 767-775 (2020).
  41. Kluesner, M. G., et al. EditR: A method to quantify base editing from Sanger sequencing. The CRISPR Journal. 1 (3), 239-250 (2018).
  42. Gripp, K. W., et al. Diamond-Blackfan anemia with mandibulofacial dystostosis is heterogeneous, including the novel DBA genes TSR2 and RPS28. American Journal of Medical Genetics Part A. 164 (9), 2240-2249 (2014).
  43. Kim, S., Kim, D., Cho, S. W., Kim, J., Kim, J. S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Research. 24 (6), 1012-1019 (2014).
  44. Ramakrishna, S., et al. Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Research. 24 (6), 1020-1027 (2014).
  45. Fu, Y., Reyon, D., Joung, J. K. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs. Methods in Enzymology. 546, 21-45 (2014).

Tags

PAM-Less Base Editing ZSpRY-ABE8e Zebrafish Modeling Human Genetic Disease Single-nucleotide Variants Adenine To Guanine Base Conversion Intermutation PAN Restriction Zebrafish Models Disease Mechanisms Drug Screening Micropipette Puller System Glass Capillaries Program Settings Pulled Capillaries Preservation ZSpRY-ABE8e MRNA Easy Edit SgRNA GRNA Design NRN PAM Sequence Target Adenine Nucleotide
Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e
Play Video
PDF DOI DOWNLOAD MATERIALS LIST

Cite this Article

Zheng, S., Liang, F., Zhang, Y.,… More

Zheng, S., Liang, F., Zhang, Y., Fei, J. F., Qin, W., Liu, Y. Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e. J. Vis. Exp. (192), e64977, doi:10.3791/64977 (2023).

Less
Copy Citation Download Citation Reprints and Permissions
View Video

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter